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or Nasal Chondrocytes to Interleukin-1b and Low Oxygen
Celeste Scotti, M.D.,1 Andrea Osmokrovic, M.D.,1 Francine Wolf, B.Sc.,1 Sylvie Miot, Ph.D.,1
Giuseppe M. Peretti, M.D.,2 Andrea Barbero, Ph.D.,1 and Ivan Martin, Ph.D.1
Previous studies showed that human nasal chondrocytes (HNC) exhibit higher proliferation and chondrogenic
capacity as compared to human articular chondrocytes (HAC). To consider HNC as a relevant alternative cell
source for the repair of articular cartilage defects it is necessary to test how these cells react when exposed to
environmental factors typical of an injured joint. We thus aimed this study at investigating the responses of HNC
and HAC to exposure to interleukin (IL)-1b and low oxygen. For this purpose HAC and HNC harvested from
the same donors (N = 5) were expanded in vitro and then cultured in pellets or collagen-based scaffolds at
standard (19%) or low oxygen (5%) conditions. Resulting tissues were analyzed after a short (3 days) exposure to
IL-1b, mimicking the initially inflammatory implantation site, or following a recovery time (1 or 2 weeks for
pellets and scaffolds, respectively). After IL-1b treatment, constructs generated by both HAC and HNC dis-
played a transient loss of GAG (up to 21.8% and 36.8%, respectively) and, consistently, an increased production
of metalloproteases (MMP)-1 and -13. Collagen type II and the cryptic fragment of aggrecan (DIPEN), both
evaluated immunohistochemically, displayed a trend consistent with GAG and MMPs production. HNC-based
constructs exhibited a more efficient recovery upon IL-1b withdrawal, resulting in a higher accumulation of
GAG (up to 2.6-fold) compared to the corresponding HAC-based tissues. On the other hand, HAC displayed a
positive response to low oxygen culture, while HNC were only slightly affected by oxygen percentage. Col-
lectively, under the conditions tested mimicking the postsurgery articular environment, HNC retained a tissue-
forming capacity, similar or even better than HAC. These results represent a step forward in validating HNC as
a cell source for cartilage tissue engineering strategies.
Introduction
In the past two decades, autologous chondrocytes im-plantation (ACI) techniques have been widely used to re-
store damaged articular surfaces.1–4 In these cell-based
techniques, autologous chondrocytes are enzymatically iso-
lated from a small biopsy of healthy articular cartilage ob-
tained in arthroscopic surgery from non-weight-bearing
zones. However, the approach is characterized by relevant
drawbacks possibly affecting the reproducibility of clinical
outcome: (1) limited chondrocytes redifferentiation after
in vitro expansion,5,6 (2) reduced chondrogenic potential of
chondrocytes from aged donors,7 and (3) morbidity to a
healthy area of the articular surface for the biopsy.3,8–10
As alternative cell source to overcome the previously cited
drawbacks of ACI and potentially improve its results, we
and others have advocated the use of human nasal septum
chondrocytes (HNC). In particular, this strategy would make
it possible (1) to obtain cartilage biopsy from the patient with
a procedure that is less invasive than removing tissue from
specific areas of the joint, (2) to reduce the donor site mor-
bidity, and (3) to reduce complications associated with the
harvesting of the biopsy. Moreover, several studies have
indicated that as compared to human articular chondrocytes
(HAC), HNC (1) proliferate faster and have a higher and
more reproducible chondrogenic capacity, both in vitro and
in an ectopic model in vivo,11–13 and (2) can generate tissues
in a quality that does not appear to be dependent on the age
of the donor.14
Once implanted in the joint, HNC would be exposed to an
environment that is biochemically and biomechanically
markedly different from their native one. We have previ-
ously reported that HNC can respond in vitro to physical
forces resembling joint loading similarly to HAC.15 How-
ever, for HNC to be considered for the repair of articular
cartilage defects, it is also crucial to explore their response to
biochemical signals typical of the injured or postsurgery
joint. In particular, cartilage covering the articular surfaces is
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exposed to a low oxygen tension, because of the lack of
vascularity,16 and, in case of intraarticular bleeding follow-
ing injury or surgery, to a transient high level of proin-
flammatory chemokines such as interleukin (IL)-1b.17
Thus, the goal of this study was to compare the responses
of HNC and HAC to IL-1b, a catabolic factor normally
present in injured and postsurgical joints, at normoxic (i.e.,
19%) or more physiologic, low oxygen (i.e., 5%) conditions.
For this purpose, considering the typically large interindi-
vidual variability in chondrocyte function,7 HAC and HNC
were isolated from the same individuals. Cells were ex-
panded in monolayers and transferred to different 3D cul-
ture systems that had previously been used as models to
investigate chondrocyte redifferentiation and synthesis of
cartilage-specific extracellular matrix proteins, namely mi-
cromass pellets and collagen-based 3D porous scaffolds.
Materials and Methods
Cartilage biopsies, chondrocyte isolation
and expansion
Healthy articular and nasal cartilage tissues were har-
vested postmortem, respectively, from full-thickness biop-
sies of the femoral condyle and from the nasal septum of
five individuals (mean age: 54 years, range 37–84 years,
male:female = 2:3), in accordance with the Local Ethical
Committee. HAC and HNC were isolated by 22 h of incu-
bation at 37C in 0.15% type II collagenase and resuspended
in Dulbecco’s modified Eagle’s medium (DMEM) containing
10% fetal bovine serum, 4.5mg/mL d-glucose, 0.1mM
nonessential amino acids, 1mM sodium pyruvate, 100mM
HEPES buffer, 100U/mL penicillin, 100 mg/mL streptomy-
cin, and 0.29mg/mL l-glutamate (complete medium, CM).
HNC and HAC were plated in culture dishes at a density of
104 cells/cm2 and expanded in CM supplemented with 1 ng/
mL of transforming growth factor b1 and 5 ng/mL of fibro-
blast growth factor 2. When subconfluent, cells were de-
tached by sequential treatment with 0.3% type II collagenase
and 0.05% trypsin/0.53mM EDTA, replated at 5· 103 cells/
cm2, and cultured until again subconfluent, corresponding to
a total of about 8 to 10 population doublings. Chondrocytes
were subsequently cultivated in 3D scaffolds or in pellets as
described below.
Culture on porous 3D scaffolds
This model was selected because it is close to a clinically
relevant approach as per cell-scaffold combination. HNC and
HAC from two donors were cultured into type I collagen
meshes (6-mm-diameter, 2-mm-thick disks, Ultrafoam,
Davol) at a density of 70 · 106 cells/cm3. Cell-scaffold con-
structs were cultured in CM supplemented with 0.1mM
ascorbic acid, 10mg/mL insulin, and 10 ng/mL transforming
growth factor-b3 (TGF-b3), with medium changes twice a
week. After 2 or 4 weeks of culture, constructs (respectively
defined as ‘‘immature’’ or ‘‘mature’’) were exposed to 50 pg/
mL human recombinant interleukin-1 beta (IL-1b) (Sigma
Chemical, St. Louis, MO) for 3 days, in a range previously
demonstrated to mimic postsurgical joint environment,18 and
then assessed or cultured for additional 2 weeks in the ab-
sence of IL-1b (see Table 1 for a detailed description of the
experimental groups). Resulting tissues were analyzed his-
tologically, immunohistochemically, biochemically, and by
quantitative real time RT-PCR as described below.
Pellet culture
This model was selected because it allows for multiple
conditions testing. HNC and HAC from three donors
were cultured in pellets using a defined serum-free medium
as previously described.7 Briefly, cells were suspended in
DMEM supplementedwith ITS+ 1 (SigmaChemical, St. Louis,
MO), 0.1mM ascorbic acid 2-phosphate, 1.25mg/mL human
serum albumin, 10–7 M dexamethasone, and 10ng/mL
TGF-b1. Aliquots of 5· 105 cells/0.5mL were centrifuged at
1000 rpm for 2min in 1.5-mL polypropylene conical tubes
(Sarstedt, Nu¨mbrecht, Germany) to form spherical pellets,
which were placed onto a 3D orbital shaker (Bioblock Scien-
tific, Frenkendorf, Switzerland) at 30 rpm. Pellets were
cultured for 7 or 14 days in a humidified incubator (37C/5%
CO2) at either normoxic condition (19% O2) or low, more
physiological oxygen tension (5% O2) as previously de-
scribed.19 Mediumwas equilibrated under 5% and 19%O2 for
Table 1. Description of the Experimental Groups
Groups Culture phase 1a IL-1b exposurea Culture phase 2a
Scaffold culture
Immature ctr 2 weeks No No
IL 2 weeks 3 days No
IL + recovery 2 weeks 3 days 2 weeks
Mature ctr 4 weeks No No
IL 4 weeks 3 days No
IL + recovery 4 weeks 3 days 2 weeks
Pellet culture
Immature ctr 1 week No No
IL 1 week 3 days No
Recovery 1 week 3 days 1 week
Mature ctr 2 weeks No No
IL 2 weeks 3 days No
IL + recovery 2 weeks 3 days 1 week
aScaffold cultures were performed at 19% oxygen and pellet cultures were performed either at 19% or 5% oxygen. ctr, control; IL, treatment
with 50pg/mL IL-1b; IL+ recovery, samples treated with 50 pg/mL IL-1b and further cultured for the indicated time in the absence of IL-1b.
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at least 6 h before each media change. After 1 (immature) or 2
(mature) weeks of culture, some of the pellets were exposed to
50pg/mL IL-1b for 3 days and immediately assessed or cul-
tured for one additional week at 19% or 5% oxygen in the
absence of IL-1b (see Table 1 for a schematic description of the
experimental groups). Resulting tissueswere cut in halves and
then analyzed histologically, immunohistochemically, and
biochemically as described below.
Biochemical analyses
Constructs and pellets were digested for 15 h at 56C with
protease K (0.5mL for pellets and 1mL for scaffolds of 1mg/
mL protease K in 50mM Tris with 1mM EDTA, 1mM io-
doacetamide, and 10 mg/mL pepstatin-A, respectively). GAG
amounts were measured spectrophotometrically after reac-
tion with dimethylmethylene blue,20 with chondroitin sulfate
as a standard. DNA was measured spectrofluorometrically
using the CyQuant cell proliferation assay Kit (Molecular
Probes, Eugene, OR), with calf thymus DNA as a standard.21
GAG contents were reported as % GAG/wet weight tis-
sue (for constructs) or GAG/DNA (for pellets). GAG
amounts were also quantified in media collected from cul-
tured constructs.
Matrix metalloproteinases (MMPs) were quantified in
media collected from cultured constructs and pellets by us-
ing the MultiAnalyte Profiling MMP base Kit (Fluorokine
MAP: LMP000) complemented with the specific MMPs
(MMP-1: LMP901; MMP-13: LMP511, R&D Systems). The
assays were performed on a Luminex 100TM analyzer fol-
lowing the manufacturer’s instructions.
Real-time quantitative RT-PCR assays
RNA of pellets was extracted using Trizol (Life Technol-
ogies, Basel, Switzerland), according to the manufacturer’s
protocol. Pellets cultured in chondrogenic medium were first
sonicated for 1min while in Trizol. RNA was treated with
DNase I using the DNA-freeTM Kit (Ambion) and quantified
spectrofluorimetrically. cDNA was generated from 3mg of
RNA by using 500mg/mL random hexamers (Catalys AG,
CH) and 1mL of 50U/mL StratascriptTM reverse transcrip-
tase (Stratagene, NL), in the presence of dNTPs. PCR reac-
tions were performed and monitored using the ABI Prism
7700 Sequence Detection System (Perkin-Elmer/Applied
Biosystems, Rotkreuz, Switzerland). Cycle temperatures and
times as well as primers and probes used for the reference
gene (GAPDH) were as previously described.7 Assays on-
Demand (Applied Biosystem) were used to measure the ex-
pression of MMP-1 (Hs00233958_m1) and MMP-13
(Hs00233992_m1). For each cDNA sample, the threshold
cycle (Ct) value of each target sequence was subtracted to the
Ct value of GAPDH, to derive DCt. The level of gene ex-
pression was calculated as 2DCt. Each sample was assessed at
least in duplicate for each gene of interest.
Histological and immunohistochemical analyses
Generated pellets and constructs were rinsed with
phosphate-buffered saline (PBS), fixed in 4% formalin,
embedded in paraffin, and cross-sectioned (5mm thick for
pellets and 7 mm thick for constructs). Sections were stained
with Safranin-O for sulfated glycosaminoglycans (GAG).
Sections were processed for immunohistochemistry using
an antibody against type II collagen (MPBiomedicals) or
Aggrecan cryptical epitope-DIPEN (MD Biosciences) as
previously described.22
Statistical analysis
For each experiment and donor, at least triplicate speci-
mens were assessed and the values were presented as
mean – standard deviation of measurements. Statistical ana-
lyses were performed using the Sigma Stat software (SPSS
Inc., Version 13). Differences between experimental groups
were assessed by two-tailed Wilcoxon tests and considered
statistically significant with p< 0.05.
Results
Anabolic responses of HAC- and HNC-based
constructs to IL-1b
HNC and HAC isolated from one donor were cultured on
Ultrafoam meshes for 2 weeks (immature) or 4 weeks (ma-
ture) and the resulting tissues exposed to IL-1b. The follow-
ing statistically significant trends were observed: (1) higher
Table 2. Biochemical Results of Constructs Generated by Human Nasal Chondrocytes












Immature, ctr 3.0 – 0.2 1.93 – 0.15 0.65 – 0.08
Immature, IL 2.5 – 0.3* 1.51 – 0.21* 21.8% 0.61 – 0.01 6.1%
Mature, ctr 6.3 – 0.4 3.80 – 1.19 0.60 – 0.05
Mature, IL 6.1 – 0.6 3.44 – 0.48 9.5% 0.56 – 0.04 6.7%
II: HNC
Immature, ctr 4.2 – 0.3# 2.96 – 0.48# 0.71 – 0.06
Immature, IL 2.9 – 0.1*,# 1.87 – 0.11*,# 36.8% 0.65 – 0.11 8.4%
Mature, ctr 8.9 – 0.5# 5.62 – 0.58# 0.63 – 0.06
Mature, IL 7.2 – 0.5*,# 4.48 – 0.48*,# 20.3% 0.62 – 0.05 1.6%
*p< 0.05 from ctr (same cell source).
#p < 0.05 vs. articular chondrocytes (same maturation extent).
ctr, control; IL, treatment with 50 pg/mL IL-1b; HNC, human nasal chondrocytes; HAC, human articular chondrocytes.
364 SCOTTI ET AL.
accumulation of GAG in mature vs. immature tissues, more
pronounced by HNC-based constructs, (2) higher GAG loss
in response to IL-1b by HNC-based constructs vs. HAC-
based constructs, and (3) superior GAG content after IL-1b
exposure in HNC-based constructs compared to HAC-based
constructs. Only minor differences in the amounts of DNA
among all experimental groups were observed (Table 2).
Immature and mature cartilaginous tissues, generated as
previously described with HAC and HNC from another
donor, were cultured for an additional 2 weeks (recovery
FIG. 1. Accumulation and release of cartilage matrix proteins by human articular chondrocytes (HAC)- and human nasal
chondrocytes (HNC)-based scaffolds. (A, B) Safranin O and (C, D) type II collagen staining of representative constructs
generated by HAC (A, C) or HNC (B, D) cultured in scaffold for a total of 2 weeks (immature) or 4 weeks (mature). Constructs
were cultured for the last 3 days with (IL-1) or without (ctr) IL-1b and then maintained for an additional 2 weeks without IL-
1b (recovery). Insets represent smaller magnifications of the constructs. Bars = 200mm. (E) Sulfated glycosaminoglycan (GAG)
content normalized to the construct wet weight. (F) GAG released in the culture medium. Values are mean – SD of triplicate
specimens obtained with cells isolated from one donor. The dashed line indicates the values displayed by samples cultured
for a total of 6 weeks without IL-1b treatment. *p < 0.05 from ctr (same cell source); #p < 0.05 vs. articular chondrocytes (same
maturation extent). Color images available online at www.liebertonline.com/tea
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time) after exposure to IL-1b. In agreement with the results of
the former experiment, both HAC- and HNC-based con-
structs matured with culture time as observed by the stron-
ger staining for GAG and type II collagen. Staining
intensities for both macromolecules were, however, always
higher in immature and mature HNC-based tissues compared
to the corresponding HAC-based ones, and remained higher
even following IL-1b exposure and the recovery time (Fig.
1A–D). The spatial distribution of GAG and type II collagen
in both HAC- and HNC-based constructs was not modulated
by the IL-1b exposure and differed between immature and
mature tissues: both extracellular matrix molecules were
mainly located in the outer region of immature specimens and
more uniformly distributed through the tissue in mature ones
(Fig. 1A–D).
Biochemical analyses confirmed that despite a superior IL-
1b-mediated GAG loss by HNC-based tissues (vs. HAC-
based ones), as evidenced by a more pronounced reduction
in the GAG contents (2.8- and 1.8-fold, respectively, for im-
mature and mature tissues), GAG content remained at higher
amounts in the tissues following IL-1b exposure (1.5- and
1.7-fold, respectively, for immature and mature tissues). In
addition, HNC-based tissues better recovered following IL-
1b withdrawal, so that the GAG contents after an additional
2 weeks of culture without IL-1b were 1.7- and 2.6-fold
higher (respectively, for immature and mature tissues) com-
pared to the corresponding HAC-based tissues (Fig. 1E).
DNA contents of both HAC and HNC tissues did not sub-
stantially differ after IL-1b exposure or recovery time (data
not shown). Analysis of culture supernatants indicated
comparable trends between HAC- and HNC-based con-
structs in the release of GAG. In particular, GAG release
decreased following IL-1b exposure of immature tissues (up
to 1.8-fold) and after the recovery time of mature tissues (up
to 2.4-fold) (Fig. 1F).
Overall, these results indicated that both HAC- and HNC-
based tissues respond to IL-1b by reducing transiently the
production (accumulation and release) of cartilage matrix
FIG. 2. Production of metalloproteases (MMP)-1 and MMP-13 by human articular chondrocytes (HAC)- and human nasal
chondrocytes (HNC)-based scaffolds. (A, B) Real time RT-PCR analysis of the expression of type MMP-1 (A) and MMP-13
mRNA (B) by HAC and HNC cultured in collagen scaffolds for 2 weeks (immature) or 4 weeks (mature) (ctr), exposed to IL-1b
(IL-1) for 3 days, and then maintained for an additional 2 weeks without IL-1b (recovery). Levels are expressed as fold of
difference from glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Values are mean – SD of measurements obtained
from triplicate specimens obtained with cells isolated from one donor. (C) MMP-13 immunohistochemical staining of im-
mature tissues. Bars = 400 mm. *p < 0.05 from ctr (same cell source); #p < 0.05 from articular chondrocytes (same maturation
extent). Color images available online at www.liebertonline.com/tea
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proteins but promptly recover following IL-1b withdrawal.
Both cartilage matrix loss and recovery were more pro-
nounced with HNC-based tissues.
Catabolic responses of HAC- and HNC-based
constructs to IL-1b
We first compared the expression of MMP-1 and -13
mRNA by HAC- and HNC-based tissues under different
culture conditions. Both tissues expressed similar basal levels
of MMP-1 and up-regulated this catabolic gene in response
to IL-1b to a similar extent (up to 131- and 77.4-fold in im-
mature and mature tissue, respectively). MMP-13 mRNA
expression levels were generally lower in HNC- vs. HAC-
based tissues under standard conditions (Fig. 2B). The
expression of both MMPs strongly decreased after 2 weeks of
recovery and reached levels measured before IL-1b exposure.
Only immature HAC-based constructs after the recovery time
expressed levels of MMP-13 higher than the basal ones (Fig.
2A and B). Immunohistochemical staining for MMP-13
overall confirmed the RT-PCR results (Fig. 2C). To evaluate
the downstream effect of MMP action, we analyzed im-
munohistochemically the tissues for the cryptic cleaved
fragment of aggrecan (DIPEN). HAC- and HNC-based
samples displayed the following similar pattern of expres-
sion of this fragment: DIPEN expression (1) was at higher
levels in immature vs. mature tissues (data not shown), (2)
increased after exposure of immature tissues to IL-1b (Fig. 3)
and decreased after the recovery culture (data not shown),
and (3) remained at low levels in mature tissues after IL-1b
exposure (data not shown).
These results indicate that HAC- and HNC-based tissues
similarly respond to IL-1b by transiently activating the pro-
duction of cartilage degradative enzymes.
Influence of low oxygen percentage
on the anabolic and catabolic responses
of HAC- and HNC-based pellets
HNC and HAC isolated from three donors were cultured
in pellets for 1 week (immature) or 2 weeks (mature) and the
resulting tissues exposed to IL-1b at different oxygen per-
centages. Safranin-O staining indicated that GAG accumu-
lation (1) was generally higher in both immature and mature
HNC-based pellets than in HAC ones, even after IL-1b ex-
posure, (2) was strongly enhanced by exposure to 5% oxygen
in HAC- but not in HNC-based pellets, and (3) recovered to a
similar extent following IL-1b withdrawal (Fig. 4A and B).
Biochemical analyses confirmed the histological results. At
19% oxygen, GAG amounts of both immature and mature
HNC-based pellets were almost double those of the corre-
sponding HAC-based pellets and remained higher even
following IL-1b exposure. Low oxygen culture at 5% oxygen
enhanced the accumulation of GAG mainly by HAC, so that
no more difference in the content of this macromolecule was
measured between the tissues generated by the two cell
types. Immature tissues generally lost higher fractions of
GAG as compared to mature counterparts in response to IL-
1b exposure. Interestingly, the IL-1b-mediated loss of GAG
was higher at 5% oxygen than 19% culture (34% vs. 20% and
42% vs. 25%, respectively, for HAC- and HNC-based pellets)
(Fig. 4C and D). DNA amounts of pellets from both cell types
were not significantly modulated by low oxygen culture or
IL-1b exposure (data not shown).
Immunohistochemical analyses of immature pellets indi-
cated that type II collagen was accumulated at higher amounts
by HNC than HAC when cultured at 19% oxygen. After IL-1b
exposure, type II collagen was almost absent in HAC-based
pellets but still detectable in scattered areas of HNC-based
FIG. 3. Accumulation of
Aggrecan cryptical epitope





of DIPEN by representative
constructs cultured for 2
weeks (ctr) and exposed to
IL-1b (IL-1) for 3 days. Bar =
200 mm. Color images avail-
able online at www
.liebertonline.com/tea
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FIG. 4. Accumulation of glycosaminoglycans by human articular chondrocytes (HAC)- and human nasal chondrocytes
(HNC)-based pellets. (A, B) Safranin O staining of representative pellets generated by HAC and HNC cultured at 19% or
5% oxygen percentage for 1 week (immature) (A) or 2 weeks (mature) (B). Pellets were cultured for the last 3 days with (IL-1)
or without (ctr) IL-1b and then maintained for an additional 2 weeks without IL-1b (recovery). Bars= 100 mm. (C, D)
Sulfated glycosaminoglycan (GAG) content of immature (C) and mature (D) pellets. Levels are expressed as fold of differ-
ence from those measured in HAC-based immature pellets at 19% oxygen. Values are mean– SD of three independent
experiments (i.e., cells from three different donors). *p< 0.05 from ctr (same oxygen percentage and cell source); p < 0.05
from 19% oxygen (same cell source and maturation extent); #p < 0.05 from articular chondrocytes (same oxygen % and
maturation extent). Color images available online at www.liebertonline.com/tea
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pellets, and remained stronger in the latter tissues after the
recovery culture. At 5% oxygen, both cell types displayed an
increase in type II collagen accumulation, with minimal dif-
ferences among them (Fig. 5). Mature pellets were more in-
tensely stained for type II collagen, with minimal differences
between cell sources and culture conditions (data not shown).
The quantification of MMP-1 and MMP-13 in the su-
pernatants of pellets revealed a similar pattern of MMPs
release by HAC and HNC. Interestingly, the basal release
of both catabolic enzymes for HAC was very low and
close to the limit of detection but relatively higher for HNC.
The released amounts of both MMPs increased following IL-
1b exposure, were higher for HNC than for HAC (up to 2.9-
and 10.4-fold, respectively, for MMP-1 and MMP-13), and
after the recovery time decreased to levels comparable to
those measured before IL-1b exposure. Almost identical
trends in the MMPs release were observed at 5% and 19%
oxygen (Fig. 6).
Discussion
In this study we compared the anabolic and catabolic re-
sponses of expanded human articular and nasal chon-
drocytes (HAC and HNC) to IL-1b and low oxygen
percentage. Both cell types responded to IL-1b by a transient
reduction of GAG and type II collagen accumulation and
increased production of MMP-1 and -13. The extent of IL-1b-
mediated cartilage matrix loss and recovery (following IL-1b
withdrawal) was more pronounced by HNC and enhanced
in HAC by a lower oxygen percentage (5% vs. 19%).
The response of articular chondrocytes to different inter-
leukin isoforms has been previously investigated by various
groups. It was demonstrated that bovine engineered carti-
lage does not grow when exposed to IL-1b after 14 days
of culture, even after a recovery period or after physiologi-
cal loading.23,24 Similar results were also reported using
porcine chondrocyte-based engineered cartilage exposed to
whole blood, in order to duplicate the postsurgical in-
traarticular bleeding, which is likely to be the major source of
IL-1b after implantation.25,26 Although interesting, those re-
sults cannot be directly compared to those of the current
study because of the use of tissues harvested from very
young animals, as opposed to human chondrocytes from
adult individuals.
The superior loss of GAG and type II collagen in response
to IL-1b and the greater expression of MMP-1 and -13 by
HNC- vs. HAC-based tissues suggested that nasal chon-
drocytes are more susceptible to IL-1b-induced damage.
These data are in agreement with those of Kozaci et al.27
indicating that the larger loss of cartilage matrix by bovine
nasal vs. articular cartilage explants in response to IL-1a was
accompanied by an enhanced MMP activity. This higher
susceptibility to matrix degradation by nasal chondrocytes
could be due to the production/activation of different deg-
radative enzymes. Nevertheless, even if a larger amount of
extracellular matrix proteins was lost by HNC in response to
IL-1b, tissues generated by HNC contained more GAG and
type II collagen after IL-1b exposure and better restored the
matrix components following a recovery time.
HAC displayed a notable increase in synthetic activity
under low oxygen tension, as already reported in the litera-
ture,19,28–30 whereas HNC were less affected by low oxygen
conditions. This finding is not in line with previously pub-
lished work reporting a positive effect of low oxygen tension
FIG. 5. Accumulation of type II collagen by human articular chondrocytes (HAC)- and human nasal chondrocytes (HNC)-
based pellets. Type II collagen staining of representative pellets generated by HAC and HNC cultured at 19% or 5% oxygen
percentage for 1 week (ctr), exposed to IL-1b (IL-1) for 3 days, and then cultured for an additional 2 weeks without IL-1b
(recovery). Bars = 100 mm. Color images available online at www.liebertonline.com/tea
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to HNC, with respect to GAG accumulation.31 The difference
could be related to the different culture conditions and ex-
perimental set-up, including the static environment as op-
posed to the bioreactor-induced hydrodynamic shear.
However, in accordance with previously published work,
our study highlights the potential importance of hypoxic
preculture of the HAC-based engineered cartilage tissues
prior to their implantation in order to optimize cell pheno-
type and cartilaginous tissue features.30 The preconditioning
could be relevant in order to mimic the anaerobic metabo-
lism of chondrocytes in articular cartilage, especially within
the deep layers.16 It is also important to consider that under
the culture conditions used in this study (i.e., static culture of
the constructs in an incubator at 5% oxygen) the oxygen
tension was likely not homogeneous throughout the tissue.
Indeed, cells in the core are expected to be exposed to lower
oxygen tensions than those in the outer regions. This could
determine heterogeneity in cell metabolism and, therefore, in
tissue organization. The culture of the constructs within
perfusion-based bioreactor culture systems allowing for a
more homogeneous mass transfer could represent a solution
to overcome this limitation. 32
In conclusion, as compared to HAC, HNC generated
cartilaginous tissues of either similar (micromass culture at
5% oxygen) or superior (micromass culture at 20% oxygen or
scaffold culture at both oxygen percentages) quality. More-
over, the stability of the tissues generated by HNC was
higher upon exposure to environmental factors typical of an
injured joint (i.e., IL-1b and low oxygen). Therefore, from a
clinical standpoint, HNC-based engineered cartilage could
have more favorable chances to successfully engraft into the
joint and regenerate the articular surface. The relevance of
these results is further strengthened by the fact that all
HAC/HNC comparisons were performed between cells
harvested from the same donor. Our findings represent an
important step forward in validating HNC as a cell source
for cartilage tissue engineering and prompt for further pre-
clinical studies in large animal models.
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FIG. 6. Release of metalloproteases (MMP)-1 and MMP-13 by human articular chondrocytes (HAC) and human nasal
chondrocytes (HNC) cultured in pellets. Amounts of MMP-1 (A) or MMP-13 (B) released by HAC- and HNC-based pellets
cultured at 19% or 5% oxygen percentage for 1 weeks (immature) or 2 weeks (mature) (ctr), exposed to IL-1b (IL-1) for 3 days,
and then cultured for an additional 2 weeks without IL-1b (recovery). Values are mean– SD of three independent experi-
ments (i.e., cells from three different donors). n.d., not detected. *p< 0.05 from ctr (same oxygen percentage and cell source);
p< 0.05 from 19% oxygen (same cell source and maturation extent); #p< 0.05 from articular chondrocytes (same oxygen %
and maturation extent).
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